Dyax Corp. (Nasdaq:DYAX), a developer of novel biotherapeutics for unmet medical needs, announced that executive management will participate in three upcoming conferenceMr. Christensen will also present at the Cowen and Company 31st Annual Health Care Conference, on Tuesday, March 8 at 11:00 AM (ET). The conference is being held March 7-9, at the Boston Marriott Copley Place in Boston, MA. At both events, Mr. Christensen will provide a corporate update regarding the Company’s three major business franchises - KALBITOR® (ecallantide), the Licensing and Funded Research Program (LFRP) and Research and Development efforts.
To read more visit: http://pennytobuck.com/?p=13077